Hyong Kim Sells 35,951 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 35,951 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the transaction, the insider directly owned 331,750 shares of the company’s stock, valued at $6,588,555. The trade was a 9.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hyong Kim also recently made the following trade(s):

• On Wednesday, March 18th, Hyong Kim sold 18,404 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total transaction of $328,327.36.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $20.60 on Wednesday. The company has a 50-day moving average of $18.59 and a 200-day moving average of $19.43. The company has a market capitalization of $4.26 billion, a price-to-earnings ratio of 228.89, a PEG ratio of 2.67 and a beta of 1.14. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same period last year, the firm earned ($0.05) EPS. As a group, equities research analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of analyst reports. Wolfe Research initiated coverage on shares of Alignment Healthcare in a report on Friday, April 17th. They set an “outperform” rating and a $24.00 price objective for the company. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Finally, UBS Group lifted their price target on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $24.30.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors have recently added to or reduced their stakes in the company. Summit Securities Group LLC bought a new position in Alignment Healthcare during the 4th quarter valued at about $26,000. Parallel Advisors LLC lifted its holdings in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC acquired a new stake in Alignment Healthcare in the 3rd quarter valued at about $33,000. First Horizon Corp acquired a new stake in Alignment Healthcare in the 4th quarter valued at about $39,000. Finally, GAMMA Investing LLC increased its position in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.